Guidance for industry : amendment (donor deferral for transfusion in France since 1980) to "Guidance for industry, revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) by blood and blood products"
| Other author | Center for Biologics Evaluation and Research (U.S.) |
| Format | Electronic |
| Publication Info | Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006] |
| Description | i, 4 p. : digital, PDF file |
| Supplemental Content | https://purl.fdlp.gov/GPO/LPS112738 |
| Subjects |
| Portion of title | Amendment (donor deferral for transfusion in France since 1980) to "Guidance for industry, revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) by blood and blood products" |
| Portion of title | Revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vDJD) by blood and blood products |
| General note | Title from PDF title page (viewed on May 18, 2009). |
| General note | "Draft guidance." |
| General note | "August 2006". |
| General note | GPO Cataloging Record Distribution Program (CRDP). |
| Bibliography note | Includes bibliographical references (p. 4). |
| Technical details | Mode of access: Internet at the FDA CBER web site. Address as of 5/18/09: http://www.fda.gov/cber/gdlns/cjdfrance.pdf ; current access is available via PURL. |
| GPO item number | 0499-T-02 (online) |
| Govt. docs number | HE 20.4802:D 71/3 |